US Patent Issued to SPRINGWORKS THERAPEUTICS on May 13 for "Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib" (Connecticut Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,925, issued on May 13, was assigned to SPRINGWORKS THERAPEUTICS INC. (Stamford, Conn.).

"Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib" was invented by Uchenna H. Iloeje (Stamford, Conn.), Abraham J. Langseth (Stamford, Conn.) and Todd Shearer (Stamford, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods for treating plexiform neurofibromas associated with neurofibromatosis type 1 (NF1-PN), comprising administering to a pediatric patient (e.g., 2 to 15 years of age) in need thereof mirdametinib or a pharmaceutically acceptable sa...